Guardant Health, Inc. (GH)
179.38
-3.72
(-2.03%)
USD |
NASDAQ |
Sep 18, 16:00
179.36
-0.02
(-0.01%)
After-Hours: 20:00
Guardant Health Enterprise Value : 24.61B for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 24.61B |
| September 17, 2026 | 25.11B |
| September 16, 2026 | 24.01B |
| September 15, 2026 | 24.11B |
| September 14, 2026 | 23.07B |
| September 11, 2026 | 21.67B |
| September 10, 2026 | 21.89B |
| September 09, 2026 | 22.39B |
| September 08, 2026 | 22.15B |
| September 04, 2026 | 22.21B |
| September 03, 2026 | 22.16B |
| September 02, 2026 | 22.43B |
| September 01, 2026 | 22.61B |
| August 31, 2026 | 21.89B |
| August 28, 2026 | 22.22B |
| August 27, 2026 | 23.16B |
| August 26, 2026 | 23.48B |
| August 25, 2026 | 22.68B |
| August 24, 2026 | 22.45B |
| August 21, 2026 | 23.45B |
| August 20, 2026 | 23.07B |
| August 19, 2026 | 22.47B |
| August 18, 2026 | 22.04B |
| August 17, 2026 | 22.24B |
| August 14, 2026 | 21.65B |
| Date | Value |
|---|---|
| August 13, 2026 | 21.96B |
| August 12, 2026 | 22.70B |
| August 11, 2026 | 22.70B |
| August 10, 2026 | 22.98B |
| August 07, 2026 | 23.15B |
| August 06, 2026 | 21.70B |
| August 05, 2026 | 22.45B |
| August 04, 2026 | 21.99B |
| August 03, 2026 | 21.87B |
| July 31, 2026 | 22.29B |
| July 30, 2026 | 21.00B |
| July 29, 2026 | 19.89B |
| July 28, 2026 | 19.83B |
| July 27, 2026 | 20.08B |
| July 24, 2026 | 20.33B |
| July 23, 2026 | 20.71B |
| July 22, 2026 | 20.79B |
| July 21, 2026 | 20.99B |
| July 20, 2026 | 20.43B |
| July 17, 2026 | 21.47B |
| July 16, 2026 | 21.35B |
| July 15, 2026 | 22.42B |
| July 14, 2026 | 22.04B |
| July 13, 2026 | 21.81B |
| July 10, 2026 | 22.03B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Natera, Inc. | 52.20B |
| NeoGenomics, Inc. | 2.850B |
| Quest Diagnostics, Inc. | 33.25B |
| Labcorp Holdings, Inc. | 32.59B |
| OPKO Health, Inc. | 1.343B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -120.14M |
| Revenue (Quarterly) | 334.98M |
| Total Expenses (Quarterly) | 455.12M |
| EPS Diluted (Quarterly) | -0.9042 |
| Gross Profit Margin (Quarterly) | 65.39% |
| Profit Margin (Quarterly) | -35.87% |
| Earnings Yield | -1.95% |
| Normalized Earnings Yield | -1.908 |